Tuesday, 01 December 2020


Rachel King is BIO chairperson for 2013-14

23 April 2013 | Influencers | By BioSpectrum Bureau

Ms Rachel King, president and CEO, GlycoMimetics is the new chair of the board of directors of Biotechnology Industry Organization (BIO)

Ms Rachel King, president and CEO, GlycoMimetics is the new chair of the board of directors of Biotechnology Industry Organization (BIO)

Singapore: Biotechnology Industry Organization (BIO) has elected Ms Rachel King, president and CEO, GlycoMimetics, as the new chair of its board of directors for the 2013-14 term and Mr David Pyott, chairman, president, and CEO, Allergan, as its new board secretary.

BIO re-elected Mr Mark Skaletsky, chairman and CEO, Fenway Pharmaceuticals, as board treasurer, and the election of 19 directors to serve on BIO's board executive committee for the new term, including Mr Ron Cohen, president & CEO, Acorda Therapeutics as health section vice chair; Mr Adam Monroe, president, Novozymes North America, Novozymes, as industrial and environmental section (IES) governing board chair; and Mr Rick Eno, president and CEO, Metabolix, as IES governing board vice chair, among others.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account